Pattern Biosciences

Pattern Bioscience is a biotech diagnostics company based in Austin, Texas, founded in 2016. The company focuses on developing innovative diagnostic solutions to address antimicrobial resistance using single-cell microbiology and machine learning technologies. Their mission is to provide targeted antimicrobial treatment information more quickly, helping to combat the global health challenge of antibiotic misuse.

The company offers culture-free diagnostic solutions that enable rapid pathogen identification and antibiotic susceptibility testing. Their technology utilizes single-cell microbiology to decode metabolic patterns of individual bacterial cells, machine learning for data analysis, and microfluidic technology to encapsulate cells for testing. This approach delivers definitive results in hours, significantly faster than traditional methods.

Pattern Bioscience targets healthcare providers in the infectious disease diagnostics market, aiming to improve patient outcomes and guide antibiotic treatment decisions. The company is privately held and currently in its Series C funding stage, having raised over $54 million to date. Their innovative technology has earned recognition, including the 2023 Disruptive Technology Award.